Skip to content
Medical Health Aged Care

Australian Private Hospitals Association CEO resigns after 24 years

Australian Private Hospitals Association (APHA) 2 mins read

Media Release

Tuesday 16 April 2024

 

Australian Private Hospitals Association CEO resigns after 24 years

The Chief Executive Officer of the Australian Private Hospitals Association (APHA), Michael Roff, has advised the Association Board he will be stepping down from the position effective Friday 5 July 2024.

Mr Roff has served the Association for the past 30 years, first as Public Affairs Manager in 1994 and was then appointed CEO in March 2000. He has represented the private hospitals sector to to nine different Federal Health Ministers and eight Prime Ministers.

“I have spent half my life and the majority of my professional life with APHA and it has been an honour to represent a sector committed to providing the highest quality health services to millions of Australians each year,” Mr Roff said.

“It has been stimulating to work at the intersection of healthcare delivery, policy and politics, and the sector has faced many challenges over the years, not least the COVID-19 pandemic when elective surgery was shut down overnight. However, after 24 years as CEO it is time to move on.

“I want to thank my staff who work tirelessly every day to support the private hospitals sector, the APHA Board who volunteer their time and expertise for the greater good of the sector and our member hospitals for their support over many years.”

APHA President Christine Gee AM said it was all but impossible to quantify Mr Roff’s contribution to the private hospital sector in just a few paragraphs.

I have had the good fortune and great pleasure to work with Michael over many years, a number of those as President of APHA. I am sure that the management of our Association could not have been in safer or more capable hands especially over the last few very tumultuous years. He can be very proud of his efforts and achievements for and on behalf of Australia’s private hospital system and the healthcare system more broadly.    

“Michael is a highly respected advocate and a consummate professional who has dedicated his skills and expertise to representing Australia’s private hospitals with the firm focus of ensuring our sector remains in the best position to provide vital and necessary services to the Australian community.

“We are grateful that Michael has offered to assist in the transition to a new CEO on a part-time basis as needed. The Board will undertake an extensive search to find APHA’s next CEO.

“The APHA Secretariat continues to offer support to members and to advocate on their behalf to government. This work remains the focus of the organisation and will not be impacted through the transition,” she said.

 

-ENDS-

Media contact: Frith Rayner, Director Communications and Marketing, 0413 971 999.

Media

More from this category

  • Medical Health Aged Care
  • 15/01/2025
  • 20:54
Glaxo SmithKline

Local scientific discovery Omjarra (momelotinib) TGA approved for Australians with rare bone marrow cancer

MELBOURNE PHOTO-FILMING OPPORTUNITY: THURSDAY 16TH JANUARY 2025 DATE: Thursday 16th January 2025 TIME: 10.30 – 11.30am LOCATION: 3 Torresdale Road, Toorak, Melbourne INTERVIEWEES: Prof…

  • Contains:
  • Medical Health Aged Care
  • 15/01/2025
  • 10:33
Monash University

The Lancet Diabetes & Endocrinology: Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease.

A global Commission, published in The Lancet Diabetes & Endocrinology and endorsed by 75 medical organisations around the world [1], presents a novel, nuanced approach to diagnose obesity, based on other measures of excess body fat in addition to body mass index (BMI), and objective signs and symptoms of ill health at the individual level. The proposal is designed to address limitations in the traditional definition and diagnosis of obesity that hinder clinical practice and healthcare policies, resulting in individuals with obesity not receiving the care they need. By providing a medically coherent framework for disease diagnosis, the Commission also…

  • Medical Health Aged Care
  • 14/01/2025
  • 17:10
Galderma

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra® and Restylane® Lyft™ or Contour™ effectively improved the facial aesthetic appearance of…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.